Laurion Capital Management LP Centogene N.V. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$9.02 - $12.93 $136,797 - $196,096	-15,166 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.44 - $13.3 $519,672 - $732,165	-55,050 Reduced 78.4%	15,166 $163,000
Q3 2020 Nov 13, 2020	BUY	$9.3 - $25.16 $511,965 - $1.39 Million	55,050 Added 362.98%	70,216 $664,000
Q1 2020 May 14, 2020	SELL	$9.76 - $23.8 $71,248 - $173,740	-7,300 Reduced 32.49%	15,166 $303,000
Q4 2019 Feb 13, 2020	BUY	$8.1 - $14.6 $181,974 - $328,003	22,466 New	22,466 $226,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.